65 WhartonS.LauD
Interestingly, there is cross-talk between sulfonylurea and incretin signaling involving the activation of the exchange protein activated by cyclic-AMP 2A (Epac2A)-Ras-like small GTPase 1 (RAP1) pathway, which may augment insulin secretion from pancreatic -cells upon exposure to the combination of both drugs [45,46]
The ELISA has a reported 88% cross-reactivity with the GLP-1 (136) amide, 93% cross-reactivity with the GLP-1 (736) amide, and non-detectable cross reactivity with the glycine-extended GLP-1 (137) amide, the GLP-1 (737) amide, and exenatide
In patients with type 2 diabetes, hypoglycemia risk was low with the higher dose and comparable to that of the lower dose and the placebo treatments
Weight regain is common if eating habits revert to pre-treatment patterns
Patients should inform their healthcare provider about all supplements and over-the-counter products they are using